Connective tissue growth factor induces cardiac hypertrophy through Akt signaling
Journal Article
·
· Biochemical and Biophysical Research Communications
- Department of Clinical Pharmacology and Pharmacogenomics, Graduate School of Pharmaceutical Sciences, Osaka University, 1-6 Yamadaoka, Suita, Osaka 565-0871 (Japan)
In the process of cardiac remodeling, connective tissue growth factor (CTGF/CCN2) is secreted from cardiac myocytes. Though CTGF is well known to promote fibroblast proliferation, its pathophysiological effects in cardiac myocytes remain to be elucidated. In this study, we examined the biological effects of CTGF in rat neonatal cardiomyocytes. Cardiac myocytes stimulated with full length CTGF and its C-terminal region peptide showed the increase in cell surface area. Similar to hypertrophic ligands for G-protein coupled receptors, such as endothelin-1, CTGF activated amino acid uptake; however, CTGF-induced hypertrophy is not associated with the increased expression of skeletal actin or BNP, analyzed by Northern-blotting. CTGF treatment activated ERK1/2, p38 MAPK, JNK and Akt. The inhibition of Akt by transducing dominant-negative Akt abrogated CTGF-mediated increase in cell size, while the inhibition of MAP kinases did not affect the cardiac hypertrophy. These findings indicate that CTGF is a novel hypertrophic factor in cardiac myocytes.
- OSTI ID:
- 21143702
- Journal Information:
- Biochemical and Biophysical Research Communications, Journal Name: Biochemical and Biophysical Research Communications Journal Issue: 2 Vol. 370; ISSN 0006-291X; ISSN BBRCA9
- Country of Publication:
- United States
- Language:
- English
Similar Records
Taxifolin protects against cardiac hypertrophy and fibrosis during biomechanical stress of pressure overload
Inhibition of cardiac hypertrophy by aromadendrin through down-regulating NFAT and MAPKs pathways
Sildenafil prevents the up-regulation of transient receptor potential canonical channels in the development of cardiomyocyte hypertrophy
Journal Article
·
Tue Sep 01 00:00:00 EDT 2015
· Toxicology and Applied Pharmacology
·
OSTI ID:22465817
Inhibition of cardiac hypertrophy by aromadendrin through down-regulating NFAT and MAPKs pathways
Journal Article
·
Fri Dec 14 23:00:00 EST 2018
· Biochemical and Biophysical Research Communications
·
OSTI ID:23105666
Sildenafil prevents the up-regulation of transient receptor potential canonical channels in the development of cardiomyocyte hypertrophy
Journal Article
·
Fri Jul 05 00:00:00 EDT 2013
· Biochemical and Biophysical Research Communications
·
OSTI ID:22239657